RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity of Maryland, Baltimore

About this trial

Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with benign tracheal stenosis

Disqualifiers

Malignancy. active infection

Trial population

patients with benign tracheal stenosis, including idiopathic, iatrogenic, autoimmune.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Biopsy or surgery

    Procedure/Surgery

    The tissue will be obtained from biopsy or surgical resection. All the "intervention" will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: patients with benign tracheal stenosis undergoing either endoscopic or surgical treatment1 intervention

Trial outcomes

Primary outcomes

1

RNA profile

The diseased mucosa will show a increased fibrosis and inflammation profile compared with that from normal mucosa

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.